This is an open label, phase II study to assess the efficacy, safety, and tolerability of Reparixin in patients with DIPSS intermediate-2, or high-risk primary…

Myelofibrosis (PMF)Post Essential Thrombocythemia Myelofibrosis (ET-MF)Post Polycythemia Vera Related Myelofibrosis (PV-MF)

~Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT05835466

Observational

Utility of the Variable Angle LCP Patella Plating System for Traumatic Patellar Fractures: A Randomized Control Trial

The Depuy Synthes Locking Compression Plate (LCP) Variable Angle Patella Plating System is an FDA approved device. The purpose of this study is to see how well…

TraumaPatella FractureKnee Cap+3 more

~Estimated

~$10 – $6,250

Hartford HospitalNCT05824676

Observational

Brief Lifestyle Medicine Preventive Randomized Prospective Interactive Educational Intervention in the Primary Care Clinic

It is widely accepted that prevention is far more impactful than curative medicine and must be included in primary care. In a previous pilot study, we evaluate…

Prevention Harmful EffectsHealth MaintenancePreventive Health Care+1 more

~Estimated

~$10 – $7,500

Trinity Health-LivoniaNCT06730737

Phase 2

MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) Trial

Low-dose MTX is a widely used, inexpensive, and safe therapy used for decades and is well tolerated by patients with rheumatologic diseases. Recently, it was i…

Polycythemia Vera (PV)Essential Thrombocythemia (ET)Myelofibrosis (MF)

~Estimated

~$10 – $6,250

Icahn School of Medicine at Mount SinaiNCT06541249

← PreviousPage 4 of 4Next →